Summary
- Current Price
- As of today, ZVSA price is $0.18, down -5.26% on
- Current Price All-Time High
- ZVSA price is currently -100.00% below its historical high of $8,750.00 set on
- Market Cap
- ZVSA current market cap is $1M, down -42.27% year-over-year
- PE Ratio
- ZVSA PE ratio is unknown
- Revenue
- ZVSA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ZVSA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | ZyVersa Therapeutics, Inc. |
| Ticker | NASDAQ: ZVSA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | zyversa.com |
| Employees | 7 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.18 | ||
| Price, 1D Change | -5.26% | |
| $1M | ||
| - | ||
| - | ||
| 0.38 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.18 | ||
| EPS, 1Y Change | +50.66% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | LSPR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.18 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.18 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$71.12 | -$1,089.67 | -1,432.15% | |
| - | -$8.48 | - | |
| -$1.23 | -$4.18 | -240.15% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -65.25% | ||
| -99.89% | ||
| -42.27% | ||
| -84.34% | ||
| 0.00% | ||
| 0.00% | ||
| +50.66% | ||
| +99.55% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.18 | ||
| $0.18 | ||
| SMA 200 vs Price | -2.33% | |
| $0.21 | ||
| SMA 50 vs Price | +19.22% | |
| 0.38 | ||
| $0.02 | ||
| 38.24 | ||
| 51.61% | ||
| 152.57% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.18 | ||
| $0.00 | ||
| - | ||
| -$6.84M | ||
| - | ||
| -$24.95M | ||
| - | ||
| -$6.84M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 0.03 | ||
| 0.03 | ||
| - | ||
| - | ||
| -661.24 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -0.12 | ||
| -0.20 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$12.39M | ||
| $101.80K | ||
| $347.90K | ||
| $347.90K | ||
| $12.73M | ||
| $12.73M | ||
| $0.00 | ||
| $0.00 | ||
| $10.12M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $24.95M | ||
| $6.84M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| -$851.70K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.11M | ||
| $0.00 | ||
| $3.69M | ||
| $0.00 | ||
| -$5.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with ZVSA
FAQ
What is the ticker symbol for ZyVersa Therapeutics, Inc.?
The ticker symbol for ZyVersa Therapeutics, Inc. is NASDAQ:ZVSA
Does ZyVersa Therapeutics, Inc. pay dividends?
No, ZyVersa Therapeutics, Inc. does not pay dividends
What sector is ZyVersa Therapeutics, Inc. in?
ZyVersa Therapeutics, Inc. is in the Healthcare sector
What industry is ZyVersa Therapeutics, Inc. in?
ZyVersa Therapeutics, Inc. is in the Biotechnology industry
What country is ZyVersa Therapeutics, Inc. based in?
ZyVersa Therapeutics, Inc. is headquartered in United States
When did ZyVersa Therapeutics, Inc. go public?
ZyVersa Therapeutics, Inc. initial public offering (IPO) was on February 11, 2022
Is ZyVersa Therapeutics, Inc. in the S&P 500?
No, ZyVersa Therapeutics, Inc. is not included in the S&P 500 index
Is ZyVersa Therapeutics, Inc. in the NASDAQ 100?
No, ZyVersa Therapeutics, Inc. is not included in the NASDAQ 100 index
Is ZyVersa Therapeutics, Inc. in the Dow Jones?
No, ZyVersa Therapeutics, Inc. is not included in the Dow Jones index
When was ZyVersa Therapeutics, Inc. last earnings report?
ZyVersa Therapeutics, Inc.'s most recent earnings report was on May 12, 2026
When does ZyVersa Therapeutics, Inc. report earnings?
The date for ZyVersa Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ZVSA Official Website www.zyversa.com
- ZVSA Profile on Yahoo Finance finance.yahoo.com/quote/ZVSA
- ZVSA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zvsa